retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Eli Lilly's shows promising weight loss results in trial The power of three: Retatrutide's
Description
With the successive launch of Glucagon-like peptide-1 (GLP-1) class drugs that allow weight loss with a once-daily pill instead of an injection, the barrier to obesity treatment is lowering
Though newer GLP-1 analogs have taken center stage, DPP-4 inhibitors were the first incretin-based therapies that paved the way for todays metabolic revolution
Psyllium helps absorb water and support healthy bowel movements, while fermentable fibers nourish beneficial gut bacteria
Stopping GLP-1 medication doesn't have to mean regaining weight
You should inject semaglutide subcutaneously, which means just under your skin
